Intralink-Spine expands clinical trials for injectable product

Spinal Tech

Spinal device company Intralink-Spine has expanded clinical trials of its Rejuve device in Australia, according to a July 14 news release.

Three things to know:

1. Rejuve is an injectable device that strengthens and stabilizes the degenerated disc.

2. Performed on an outpatient basis, Rejuve can be used as an adjunct or replacement to surgeries, including discectomies, spinal fusions and spinal implants.

3. The device is intended for the treatment of degenerative disc disease, lumbar pain and associated spinal diseases.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers